T 0134/23 (Methods for recombinantly expressing a polypeptide of interest/NOVARTIS) of 14.05.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T013423.20250514
- Date of decision
- 14 May 2025
- Case number
- T 0134/23
- Online on
- 12 May 2026
- Petition for review of
- -
- Application number
- 15739327.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NOVEL VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST
- Applicant name
- Novartis AG
- Opponent name
- Strawman Limited
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Main request and auxiliary requests 1 to 8 - Inventive step - (no)
Auxiliary request 9 - Novelty - (no)
Auxiliary request 10 - requirements of the EPC met (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the claims 1 to 9 of auxiliary request 10 filed on 5 October 2022 and a description and drawings eventually to be adapted thereto.